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Mercury is a heavy metal that enters the
environment from both natural and anthro-
pogenic sources. A natural element in the
earth’s crust, Hg is converted by bacteria to
methylmercury (MeHg) in lakes and oceans
and bioaccumulates in the marine food
web. Hg is also released into the environ-
ment through human activities, mainly
burning of fossil fuels and waste incinera-
tion. Polychlorinated biphenyls (PCBs) and
chlorinated pesticides are organochlorine
compounds (OCs), a family of lipophilic
compounds used extensively in North
American and European industry and agri-
culture from 1930 to the mid-1980s (1,2).
OCs have been dispersed widely in the envi-
ronment. Even in industrialized countries
where they are no longer being manufac-
tured, they are still detectable in the environ-
ment because they resist degradation, are
released into the environment by inadvertent
spills and careless disposal, and in some
countries are still in use (3). The PCBs used
for industrial purposes were complex mix-
tures of various congeners, each with its own
unique molecular structure and potentially
different toxicological effects.
OCs and heavy metals are carried from
industrialized countries to the Arctic by
long-range atmospheric transport, water-
ways, and oceanic currents (4). Due to their
high lipophilicity and resistance to biodegra-
dation, OCs bioaccumulate in fatty tissues of
organisms and are biomagniﬁed through the
food chain, producing relatively high con-
centrations in the fat of predator species (5).
In lakes and oceans, Hg is converted by bac-
teria to methylmercury (MeHg) and bioac-
cumulates in fish and in the meat of sea
mammals who eat MeHg-contaminated ﬁsh.
Because ﬁsh and marine mammals represent
an important part of the diet of the Inuit,
exposure to OCs and Hg are of particular
interest for public health authorities in the
Arctic regions. Elevated levels of PCBs and
Hg in Inuit adults have been reported by
Dewailly et al. (6,7) in northern Québec
and by Bjerregaard et al. (8) in Greenland.
High PCB and Hg concentrations have
been reported by Bjerregaard and Hansen
(9) among Greenlandic Inuit mothers and
newborns.
The developmental neurotoxicity of
MeHg ﬁrst became evident during the 1950s
at Minimata Bay, Japan, which was heavily
contaminated with Hg from industrial efﬂu-
ent entering the bay. A second well-docu-
mented MeHg poisoning occurred in Iraq in
the 1970s when seed grain contaminated
with a MeHg fungicide was used to make
homemade bread (10). The neurodevelop-
mental effects seen in children exposed in
utero in both Japan and Iraq included
severe sensory and central nervous system
impairments (11,12). Three well-designed,
prospective, longitudinal studies that exam-
ined the effects of prenatal exposure to
lower doses of MeHg on childhood cogni-
tive function were performed in New
Zealand, Faroe Islands, and Seychelles
Islands (13–17). In the Faroe Islands study,
MeHg exposure was found to be related to
poorer performance in the domains of fine
motor function, attention, language,
visual–spatial abilities, and verbal memory
(15,18). Although no adverse effects were
found in the Seychelles study (16,19,20),
the New Zealand study, which was similar
in exposure and research design, found
Address correspondence to G. Muckle, Public Health
Research Unit, CHUQ Research Center (CHUL),
2400 D’Estimauville, Beauport (Québec), Canada,
G1E 7G9. Telephone: (418) 666-7000, ext. 360.
Fax: (418) 666-2776. E-mail: Gina.Muckle@
crchul.ulaval.ca
We are grateful to the Nunavik population for
their participation in this research. We thank the
medical and health care professionals from the
Inuulitsivik Health Center and the nursing stations
in Puvirnituq, Inukjuaq, and Kuujjuaraapik for their
assistance in recruiting this cohort. We gratefully
acknowledge the support of the Nunavik Nutrition
and Health Committee, the Municipal Councils of
Puvirnituq, Inukjuaq, and Kuujjuaraapik, the
Pauktuutit Inuit Women’s Association, and the
Nunalituqait Ikaluqatigiitut Association. The techni-
cal assistance of the professionals from the Centre de
Toxicologie du Québec regarding laboratory analysis is
acknowledged. We are grateful to G. Lebel for his
involvement in the management of the exposure
data, and to C. Bouffard, L. Chiodo, J. Gagnon, E.
Lachance, K. Poitras, B. Tuttle, and C. Vézina for
their committed involvement in all phases of the
data collection and instrument coding processes. 
This study was made possible by grant number
R01-ES07902 from the National Institute of
Environmental Health and Sciences/NIH, and
grants from Indian and Northern Affairs Canada
(Northern Contaminants Program), Health
Canada, and Hydro-Québec (Environmental Child
Health Initiative).
Received 16 March 2001; accepted 1 June 2001.
Articles
The Inuit population residing in Nunavik (northern Québec, Canada) relies on species from the
marine food web for subsistence and is therefore exposed to high doses of environmental contam-
inants such as polychlorinated biphenyls and methylmercury and to a lesser extent lead. In view
of the neurotoxic properties of these substances following developmental exposure, we initiated a
study on infant development in this remote coastal population. Here we report the magnitude of
prenatal exposure to these contaminants and to selective nutrients in Inuit mothers and their
newborns who were recruited on the Hudson Bay coast. We conducted interviews during the
women’s pregnancies and at 1 and 11 months postpartum and collected biological samples for
mercury, lead, polychlorinated biphenyls (PCBs), and chlorinated pesticides analyses as well as
selenium and N-3 polyunsaturated fatty acids (n3-PUFA). Cord blood, maternal blood, and
maternal hair mercury concentrations averaged 18.5 µg/L, 10.4 µg/L, and 3.7 µg/g, respectively,
and are similar to those found in the Faroe Islands but lower than those documented in the
Seychelles Islands and New Zealand cohorts. Concentrations of PCB congener 153 averaged
86.9, 105.3, and 131.6 µg/kg (lipids) in cord plasma, maternal plasma, and maternal milk,
respectively; prenatal exposure to PCBs in the Nunavik cohort is similar to that reported in the
Dutch but much lower than those in other Arctic cohorts. Levels of n3-PUFA in plasma phospho-
lipids and selenium in blood are relatively high. The relatively low correlations observed between
organochlorine and methylmercury concentrations may make it easier to identify the specific
developmental deficits attributable to each toxicant. Similarly, the weak correlations noted
between environmental contaminants and nutrients will facilitate the documentation of possible
protective effects afforded by either n3-PUFA or selenium against neurotoxic contaminants. Key
words: Canada, chlorinated pesticides, environmental contaminants, human exposure, Inuit, lead,
mercury, polychlorinated biphenyls, polyunsaturated fatty acids, selenium. Environ Health
Perspect 109:1291–1299 (2001). [Online 30 November 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p1291-1299muckle/abstract.html
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Articlepoorer performance in domains similar to
those observed in the Faroe study (13,14). 
The developmental toxicity of heat-
degraded PCBs was ﬁrst recognized in Japan
in the late 1960s and in Taiwan in the late
1970s. In both countries, infants born to
women who had consumed rice oil contami-
nated with mixtures of PCBs and polychlori-
nated dibenzofurans (PCDFs) exhibited skin
rashes and poorer intellectual functioning
during infancy and childhood (21,22). The
effects of prenatal exposure to background
levels of PCBs and other OCs from environ-
mental sources have been studied since the
1980s in prospective longitudinal studies. In
Michigan, prenatal PCB exposure was associ-
ated with poorer visual recognition memory
in infancy (23–25), an effect recently con-
ﬁrmed in the Oswego study (26). In North
Carolina, deficits in psychomotor develop-
ment were seen in the most highly exposed
children through 24 months of age (27,28).
In Michigan, prenatal PCB exposure was
linked to poorer intellectual function at 4
and at 11 years (24,29), a ﬁnding conﬁrmed
at 42 months in the Netherlands (30). 
Low levels of postnatal lead exposure
have been linked to poor childhood cognitive
performance in several studies (31,32).
Although prenatal lead exposure at back-
ground levels is associated with adverse
effects on cognitive function during infancy,
these effects have generally been transient and
are no longer evident during childhood (33).
Neurotoxic effects of MeHg might be
attenuated by protective effects of nutrients
such as selenium, and adverse effects from
OCs might be attenuated by a high intake of
N-3 polyunsaturated fatty acids (n3-PUFA).
Increased intake of Se and n3-PUFA would
be expected in a population who consume
relatively large quantities of ﬁsh and marine
mammals. Although the effects of Se on
MeHg toxicity have not been well docu-
mented in humans, there is evidence from
over 40 animal studies that Se can inﬂuence
the deposition of Hg in the body and protect
against its toxicity (34). n3-PUFA, especially
DHA, are essential for brain development
(35). DHA deficiency impairs learning and
memory in rats (36), and rodents and non-
human primates fed diets severely deﬁcient in
n3-PUFA show altered visual function and
behavioral problems (37). Supplementation
of n3-PUFA can enhance visual acuity and
brain development in preterm human infants
(38,39), although it is not clear whether
increased levels of these nutrients can beneﬁt
full-term infants (40). Therefore, n3-PUFA
may protect against neurotoxicity associated
with prenatal exposure to environmental
contaminants.
We are currently conducting a prospec-
tive longitudinal study to examine the effects
of pre- and postnatal exposure to OCs and
MeHg on cognitive and behavioral develop-
ment in a sample of Inuit infants in north-
ern Québec (Nunavik). Whereas Dewailly et
al. (6,7) examined contaminant exposure in
Nunavik Inuit adults, here we focus speciﬁ-
cally on levels of exposure in infants during
the period of development when humans
appear to be most vulnerable. We report on
the concentrations of OCs, Hg, and lead in
biological samples from our Nunavik cohort
of mothers and newborns and compare their
levels with those found in other develop-
mental studies. In addition, we examine the
degree to which exposure to neurotoxicants
tends to be elevated in the same individuals.
Finally, in view of the unique source of
exposure to OCs and heavy metals in this
population (marine food web), we document
circulating levels of Se and n3-PUFA, which
may afford protection against exposure to
neurotoxicants.
Materials and Methods
Population. Pregnant Inuit women from
Nunavik were invited to participate in a
study focusing on infant health and develop-
ment. The Nunavik region is located north
of the 55th parallel, about 1,500 km from
Montreal and 2,000 km from the Great
Lakes in the United States (Figure 1). About
7,660 Inuit live in 14 villages scattered along
a 2,000-km seashore line along Hudson Bay,
Hudson Strait, and Ungava Bay. The study
participants were living in Puvirnituq
(50%), Inukjuaq (37%), and Kuujjuaraapik
13%), the three largest communities on the
Hudson Bay coast. 
Procedures and variables. From
November 1995 to March 2001, a midwife
or nurse in each of three targeted communi-
ties gave our research assistant the name of
each pregnant woman shortly after her ﬁrst
prenatal visit. Our research assistant then
contacted the potential participant by tele-
phone and invited her to meet at the com-
munity nursing station to learn about the
study’s objectives and procedures. Women
without telephones (24% of the sample)
were contacted by an announcement on the
community’s FM radio station asking them
to contact our research assistant. A detailed
informed consent was obtained from each
participating mother. The research proce-
dures were approved by the human subjects
committees of Laval University and Wayne
State University. Interviews were conducted
in the community’s nursing station at mid-
pregnancy and at 1, 6, and 11 months post-
partum by trained research assistants to
assess the mothers’ socioeconomic and per-
sonal characteristics. Among the 333
Nunavik women invited to participate in
this study through April 2000, 13.5% were
excluded because a newborn from the same
mother had been previously recruited, 2.4%
could not be contacted by our research assis-
tants, and 18.5% refused to participate.
Among the women interviewed prenatally,
4.5% were subsequently excluded for mis-
carriage or perinatal or postnatal mortality;
5.6% for failure to obtain the biological
samples needed to document maternal PCB
and Hg body burden; 3.4% for relocation to
another village; and 2.8% for the adoption
of the newborn by residents of another vil-
lage; 3% chose to withdraw from the study.
A 30-mL blood sample was obtained
from the umbilical cord after it was severed.
A 12.5-mL blood sample was obtained from
each participating mother at delivery or
within a few weeks thereafter [median = 6
days; interquartile range (IQR) = 0–6.6
weeks]. Two 5-mm diameter hair samples
were collected from the mother, one at the
prenatal interview (median = 21 weeks of
pregnancy; IQR = 17–28 weeks) and one at
the 1-month postnatal interview (median =
35 days; IQR = 17–59 days). A 10-mL milk
sample was collected from breast-feeding
mothers at the 1-month postnatal interview
(median= 35 days; IQR = 17–59 days).
PCB congener and chlorinated pesticide
concentrations were measured in cord and
maternal plasma and breast milk. Hg con-
centrations were determined in cord and
maternal whole blood, as well as in the hair
sample collected postnatally, which was cut
into three segments of 3 cm in length, with
each segment corresponding to a trimester
of pregnancy. The hair samples were long
enough to represent the whole pregnancy
(≥ 9 cm) for all participants except one for
whom the sample collected prenatally was
used in addition to the postnatal sample.
Lead concentrations were measured in cord
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Figure 1. Nunavik Region in northern Québec,
Canada.blood, Se concentrations in cord and mater-
nal blood, and n3-PUFA in cord plasma.
Laboratory procedures. Analyses of OCs,
Hg, lead, and Se were performed at the labo-
ratory of the Centre de Toxicologie du Québec,
which is accredited by the Canadian
Association for Environmental Analytical
Laboratories. Blood samples containing
EDTA as the anticoagulant were centrifuged
and the plasma was collected in glass vials
prewashed with hexane. Plasma samples were
stored at –80°C until analysis. A 1:1:3 mix-
ture of ammonium sulfate:ethanol:hexane
was ﬁrst added to the plasma to extract OCs.
The extracts were then concentrated and
purified on two Florisil columns (60–100
mesh; Fisher Scientific, Nepean, Ontario,
Canada). The 14 most prevalent PCB con-
geners (IUPAC nos. 28, 52, 99, 101, 105,
118, 128, 138, 153, 156, 170, 180, 183, and
187) and 11 chlorinated pesticides or their
metabolites [aldrin, α-chlordane, γ-chlor-
dane, p,p´-dichlorodiphenyltrichloroethane
(DDT), p,p´-dichlorodiphenyldichloroethene
(DDE), hexachlorobenzene (HCB), β-hexa-
chlorocyclohexane (HCH), mirex, cis-
nonachlor, trans-nonachlor, oxychlordane]
were measured in the puriﬁed extracts with
an HP 5890 high-resolution gas chromato-
graph equipped with dual-capillary columns
(HP Ultra I and Ultra II) and dual Ni-63
electron capture detectors (Hewlett-Packard,
Palo Alto, CA, USA). Quality control proce-
dures were described previously (41). Percent
recovery ranged from 89% to 100%, and the
detection limit was approximately 0.02 µg/L
for all compounds. Coefﬁcients of variation
(n = 20, different days) ranged from 2.1% to
9.1%. Biases—the difference between the
concentration of the reference material and
the concentration found using the analytic
method—ranged from –10.9% to 3.8%. 
The same OCs were measured in milk
samples using a similar procedure. Com-
pounds were initially extracted from milk
using a mixture of acetone/hexane, followed
by a second extraction with hexane alone.
Combined organic phases were washed with
deionized water, concentrated, and puriﬁed
on activated Florisil columns. A mixture of
dichloromethane/hexane was used to elute
the compounds, which were separated and
quantified by HRGC as described above.
Detection limits vary from 0.6 to 2.0 µg/kg
lipids for the various OCs. We used two cer-
tified milk reference materials (CRM 188
and 450) to assess precision and accuracy of
the method. Coefﬁcients of variation varied
from 10% to 20% and biases from 5% to
15%, depending on the speciﬁc organochlo-
rine. Because OCs distribute mainly in
body fat, concentrations in plasma and
milk samples are reported in micrograms
per kilogram of lipids. We measured total
cholesterol, free cholesterol, and triglycerides
in plasma samples by standard enzymatic pro-
cedures, but determined phospholipids
according to the enzymatic method of
Takayama et al. (42), using a commercial kit
(Wako Pure Chemical Industries, Richmond,
VA, USA). We estimated the concentration
of total plasma lipids according to the formula
developed by Phillips et al. (43). We weighed
an aliquot of the milk fat extract to determine
the concentration of lipids in milk samples.
We determined total mercury concentra-
tions in samples of cord and maternal blood
and maternal hair by cold vapor atomic
absorption spectrometry. Samples were
digested with nitric acid and mercury was
reduced by adding anhydrous stannous chlo-
ride (SnCl2) and cadmium chloride (CdCl2).
Metallic mercury was volatilized and detected
by atomic absorption spectrometry (Model
120; Pharmacia, Piscataway, NJ, USA). The
detection limit for blood mercury analysis
was 1.0 nmol/L. Quality control procedures
were described previously (41). Coefﬁcients
of variation (n = 50, different days) at levels
of 40 and 90 nmol/L (in-house reference
materials) were 5% and 5.5%, respectively.
Relative biases were 2.4% and –0.4%,
respectively. The detection limit for hair mer-
cury analysis was 1 nmol/g. We obtained
accuracy and precision data using certified
reference material through Health Canada’s
hair mercury inter-laboratory comparison
program. Coefficients of variation (n = 50,
different days) were 4.8% for the 12.3 µg/g
reference specimen (CRM 397) (44) and
4.3% for the 4.42 µg/g reference specimen
(CRM 13) (45). The relative biases were
–2.2% and +1.9%, respectively.
We diluted an aliquot of whole blood
with a mixture of nitric acid, ammonium
phosphate, and Triton X-100 and analyzed
it for lead by graphite furnace atomic
absorption with Zeeman background correc-
tion (model ZL 4100; Perkin Elmer,
Norwalk, CT, USA). The detection limit of
the method is 50 nmol/L. We used four ref-
erence specimens of 2.8, 2.1, 1.2, and 0.3
µmol/L to calibrate the analytic method for
lead; the corresponding coefﬁcients of varia-
tion were 2.4%, 2.9%, 2.3%, and 5.0%, and
relative biases were +2.0%, +2.2%, –0.8%,
and –0.2%, respectively (n = 10).
We determined blood Se concentrations
with inductively coupled plasma mass spec-
trometry (ICP-MS) using state-of-the-art
instrumentation (PE Elan 6000; Perkin
Elmer). Samples were diluted and aspirated
into the instrument. We performed matrix-
matched calibration using a pool of normal
blood. We obtained accuracy and precision
data using reference material from our
ICP-MS comparison program. The detection
limit was 0.1 µmol/L. The coefﬁcient of vari-
ation (n = 37, different days) at a level of 2.7
µmol/L was 5.9%, and the bias was –0.4%.
The fatty acid composition of plasma
phospholipids was determined by the Lipid
Analytical Laboratory at the University of
Guelph (B.J. Holub). A 200-µL aliquot of
plasma was extracted following the addition
of chloroform:methanol (2:1, v/v), in the
presence of a known amount of internal
standard (diheptadecanoyl phospholipid).
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Table 1. Characteristics of participants.
Characteristics Total no. Mean SD Range No. Percent
Marital status (% single) 175 53 30.3
Age 175 24.6 5.67 14.1–40.7
Education 175 8.8 1.62 6.0–14.0
Socioeconomic statusa 172 25.6 10.39 8.0–50.0
Unskilled laborers 55 32.0
Semiskilled workers 51 29.7
Skilled craftsmen, clerical, and sales 52 30.2
Technical, small business 14 8.1




Breast-feeding status (% breast-fed)b 146 140 95.9
aHollingshead Index (46) for the mother and her partner or, if she was not self-supporting, for her primary source of sup-
port (usually her parents). bAmong nonadopted infants. 
Table 2. Concentrations of mercury in blood and hair. 
Arithmetic Geometric
Mercury concentrations No. mean mean SD Range IQR
Cord blood (µg/L) 95 22.7 18.5 0.4 2.8–97.0 12.0–27.2
Maternal blood (µg/L) 130 12.6 10.4 0.4 2.6–44.2 6.6–17.0
Maternal hair (µg/g)a 123 4.5 3.7 1.9 0.3–14.0 2.5–6.2
Maternal hair, ﬁrst trimester (µg/g) 124 4.4 3.5 2.0 0.2–18.5 2.2–6.1
Maternal hair, second trimester (µg/g) 124 4.6 3.6 2.1 0.4–16.3 2.3–6.6
Maternal hair, third trimester (µg/g) 125 4.4 3.7 1.9 0.3–12.8 2.4–6.0
aAverage of concentrations found at ﬁrst, second, and third trimesters of pregnancy.Total phospholipids were isolated from the
lipid extract by thin-layer chromatography
using heptane:isopropyl ether:acetic acid
(60:40:3, v/v/v) as the developing solvent.
After transmethylation using BF3/methanol,
the fatty acid proﬁle was determined by cap-
illary gas-liquid chromatography. Fatty acid
concentrations in plasma phospholipids were
expressed as percentages of the total area of
all fatty acid peaks from C14:0 to C24:1
(percent weight).
Results
Sample sociodemographic characteristics are
summarized in Table 1. A large proportion
of women were single, 15% were younger
than 18 years, and 5% were older than 35.
Only 17% of participants had obtained their
high-school diploma. Twenty-three percent
of the participating women were primi-
parous, and 32% had already delivered three
or more children. Most of the interviews
were conducted in English. Most women
(90%) smoked during pregnancy (data not
shown). Descriptive statistics for the blood
and hair Hg analyses are presented in Table
2. The average Hg concentration is 1.8 times
higher in cord blood than in maternal blood,
and the average hair Hg concentrations are
similar during all three trimesters of preg-
nancy. The intercorrelations among blood
and hair Hg concentrations are presented in
Table 3. The cord blood–maternal blood
correlation is very high, and even a little
higher when only maternal blood samples
collected within 1 month of delivery are con-
sidered (n = 51, r = 0.93). Cord blood Hg
concentrations are moderately related to
maternal hair Hg concentrations. Given that
the cord blood Hg concentration primarily
reflect recent exposure, it is not surprising
that the cord blood Hg concentrations are
more strongly related to third-trimester hair
Hg concentrations than to those measured in
samples corresponding to earlier trimesters.
Cord blood lead concentrations average 0.2
µmol/L, which corresponds to 41.4 µg/L 
[n = 95, geometric mean = 0.2 µmol/L, geo-
metric standard deviation (SD) = 2.0, range =
0.0-0.9, IQR = 0.1–0.3 (data not shown)].
Tables 4, 5, and 6 show the descriptive
statistics for the 14 PCB congeners and 11
chlorinated pesticides in cord plasma, mater-
nal plasma, and breast milk, respectively.
The most prevalent congeners in all three
media are 153, 138, and 180. These three
congeners represent about 66% of the total
concentration of the 14 PCB congeners in
all three media. The next most prevalent
congeners are 99, 118, 170, and 187, and
the least prevalent are 52, 101, 105, 156,
183, and 187. The intercorrelations among
congeners detected in at least 70% of cord
plasma and breast milk samples are presented
in Table 7. These intercorrelations are very
high in cord plasma, ranging from 0.71 to
0.98 (median r = 0.90). The intercorrelations
in maternal plasma are similar [median r =
0.90; range = 0.62–0.99 (data not shown)].
The magnitude of the intercorrelations
among the seven congeners that are readily
detected in cord and maternal plasma is simi-
lar in breast milk, but the intercorrelations
with the lowest chlorinated congeners (52,
101, and 105) are somewhat weaker. On the
basis of these data, it seems reasonable to use
PCB congener 153, the most prevalent con-
gener, as a marker for exposure to the envi-
ronmental PCB mixture in the Arctic. 
The predominant chlorinated pesticides
are p,p´-DDE, HCB, oxychlordane, and
trans-nonachlor (Tables 4, 5, and 6). The
pesticide p,p´-DDT, which is much less per-
sistent than its main metabolite, p,p´-DDE,
constitutes a very small proportion (< 8%) of
the total DDT (p,p´-DDT + p,p´-DDE)
concentrations in biologic samples. The
intercorrelations among the chlorinated pes-
ticides detected in at least 70% of samples
are presented in Table 8 for the cord plasma
and breast milk samples. These intercorrela-
tions are strong in both cord plasma (median
r = 0.76) and breast milk (median r = 0.79).
The chlorinated pesticides measured in both
media are strongly associated with PCB con-
gener 153, except for p,p´-DDT where the
association is moderate, presumably because
the p,p´-DDT concentration is low, close to
the detection limit, and is more transitory
and more specifically reflective of recent
exposure. 
PCB and chlorinated pesticide concen-
trations are lowest in cord plasma and high-
est in breast milk. For example, the average
cord plasma concentration of congener 153
is 84.4% of its average concentration in
maternal plasma, and its average concentra-
tion in maternal plasma is 83.6% of that in
breast milk. Although concentrations dif-
fered among the three media, correlations
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Table 3. Intercorrelations among blood and hair mercury concentrations.
Cord Maternal Hair, Hair, ﬁrst Hair, second Hair, third
Source blood blood averaged trimester trimester trimester
Cord blood 0.88* (61) 0.64* (72) 0.42* (73) 0.55* (72) 0.80* (73)
Maternal blood 0.71* (95) 0.60* (96) 0.63* (96) 0.74* (97)
Maternal hair, averageda 0.94* (123) 0.98* (123) 0.92* (123)
Maternal hair, ﬁrst trimester 0.91* (123) 0.74* (124)
Maternal hair, second trimester 0.87* (124)
Values shown are Pearson r (n). 
aAverage of the total mercury concentrations found at ﬁrst, second, and third trimesters of pregnancy. *p ≤ 0.000. 
Table 4. Descriptive statistics for PCB congeners and chlorinated pesticides concentrations detected in
at least 70% of cord plasma samples (n = 98).
Percent Arithmetic Geometric Total
detected mean mean SD Range IQR PCBs
PCBs (µg/kg)
Congener 28 6.1
Congener 52  24.5
Congener 99 94.9 22.1 17.2 2.0 2.8–116.8 11.2–26.0 6.3
Congener 101  18.4
Congener 105  14.3
Congener 118 86.7 17.1 13.0 2.1 2.8–97.4 8.5–20.8 4.89
Congener 128 0
Congener 138 100 70.7 54.8 2.0 10.1–313.1 34.0–92.4 20.2
Congener 153 100 116.0 86.9 2.2 13.4–550.9 51.8–148.7 33.1
Congener 156  38.8
Congener 170 76.5 17.5 12.3 2.3 2.8–65.3 5.9–23.1 5.0
Congener 180 100 45.0 33.4 2.2 6.1–164.2 19.8–55.8 12.8
Congener 183  36.7
Congener 187 93.9 20.6 16.7 1.9 3.8–65.3 11.6–27.8 5.9




p,p´-DDE 100 387.9 305.2 2.0 55.7–1773.4 208.2–467.3
p,p´-DDT 71.4 16.6 13.6 1.9 4.2–58.2 7.5–21.2
Mirex 31.6
HCB 100 55.6 45.6 1.9 10.6–233.6 29.9–69.0
α-Chlordane 0
γ-Chlordane 0
cis-Nonachlor 73.5 13.7 10.6 2.1 2.8–43.7 5.3–18.0
trans-Nonachlor 100 60.6 48.2 2.0 7.4–196.0 33.0–77.8
Oxychlordane 95.9 39.0 28.6 2.3 2.8–191.3 19.0–53.1
aSum of all 14 congeners including congeners not detected in at least 70% of samples.among PCB congener 153 concentrations in
cord plasma, maternal plasma, and breast
milk are very high (cord plasma–maternal
plasma, r = 0.93; cord plasma–breast milk, r
= 0.91; maternal plasma–breast milk, r =
0.95). The strength of these associations
does not change when the same Pearson cor-
relation analyses are performed using only
the maternal plasma samples collected
within 1 month after delivery (data not
shown).
The intercorrelations between PCB con-
gener 153 and Hg are modest: cord PCB–
cord Hg, r = 0.24; cord PCB–average hair
Hg, r = 0.34; maternal PCB–average hair
Hg, r = 0.17. The associations between con-
centrations of lead and Hg in cord blood are
also low (0.21–0.29). The intercorrelations
between cord blood lead and OC concentra-
tions are even weaker, whether OCs are
measured in cord plasma, maternal plasma,
or breast milk (0.06–0.16). 
Cord blood Se concentrations average
3.8 µmol/L (geometric mean = 3.5, SD =
1.4, range = 1.9–11.6, IQR = 2.8–4.3, n =
93). Maternal blood Se concentrations aver-
age 4.5 µmol/L (geometric mean = 4.1, SD
= 1.4, range = 1.9–15.6, IQR = 3.2–5.0, n =
130). Docosahexaenoic acid (DHA) average
3.6% of total phospholipids in cord plasma
(geometric mean = 3.5, SD = 1.4, range =
1.1–7.5, IQR = 2.7–4.3, n = 97). The inter-
correlations among the environmental cont-
aminants, Se and DHA are presented in
Table 9. Cord blood Se concentrations are
weakly associated with cord plasma PCB
153 but moderately associated with cord
blood, maternal blood, and hair Hg concen-
trations. DHA is weakly correlated with
PCB 153 and moderately associated with
Hg concentrations. None of these nutrients
are associated with cord lead concentrations.
Discussion
These data conﬁrm that prenatal exposure to
Hg among the Inuit of Nunavik is higher
than that observed in general population
samples in Canada and the United States
(41,47). Hg concentrations reported in other
cohorts are presented in Table 10. When
compared with cohorts with relatively high
concentrations that were selected to examine
the neurobehavioral effects of prenatal Hg
exposure, the Hg exposure in Nunavik Inuit
is similar to that observed in the Faroe
Islands first and second cohorts (18,48),
slightly lower than in the Seychelles Islands
cohorts (17,20), and substantially lower than
in the highest exposed group in the New
Zealand study (14). Hg exposure in the
Inuit is also markedly lower than in another
northern Québec aboriginal population, the
Cree, in 1977–1978, but slightly higher
than the average concentration observed in
the same population more recently in 1992
(49,50). Compared with Greenlandic Inuit
from the Disko Bay region (9), the Nunavik
Hg exposure is lower. Because the intercor-
relation between cord Hg and cord OC con-
centrations is low in the Nunavik cohort, it
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Table 5. Descriptive statistics for PCB congeners and chlorinated pesticides concentrations detected in
at least 70% of maternal plasma samples (n = 159). 
Percent Arithmetic Geometric Total




Congener 99 100 24.4 19.1 2.0 3.3–124.8 12.1–29.1 6.1
Congener 101 62.3
Congener 105  74.2 4.4 3.4 2.0 0.95–25.8 2.0–5.4 1.1
Congener 118 98.7 18.1 14.3 2.0 1.3–100.9 8.9–19.9 4.7
Congener 128 15.1
Congener 138 100 73.8 57.8 2.0 10.2–387.1 36.8–93.9 18.6
Congener 153 100 137.4 105.3 2.1 18.9–709.0 64.5–166.7 34.6
Congener 156  93.7 8.5 6.4 2.1 1.1–44.6 3.5–10.6 2.1
Congener 170 99.4 23.3 16.9 2.2 1.3–148.3 9.1–29.8 5.9
Congener 180 100 58.9 43.8 2.1 7.6–383.5 25.3–72.8 14.8
Congener 183  96.9 9.4 7.4 2.0 1.3–44.8 4.7–11.5 2.4
Congener 187 100 26.6 21.3 1.9 3.3–127.8 13.7–32.9 6.7
Σ 14 congenersa 397.3 313.2 2.0 71.3–1951.3 197.9–489.2
Chlorinated pesticides (µg/kg)
Aldrin 0.6
β-HCH 74.2 7.0 5.6 1.9 1.3–31.2 3.6–8.9
p,p´-DDE 100 386.3 307.3 1.9 58.8–2268.1 198.1–485.5
p,p´-DDT 93.1 18.8 14.0 2.2 1.9–133.8 8.8–22.9
Mirex 93.7 11.7 8.8 2.2 1.0–60.2 5.4–14.5
HCB 100 51.1 42.0 1.9 6.7–352.6 28.6–63.6
α-Chlordane 0
γ-Chlordane 5.0
cis-Nonachlor 96.2 16.9 13.2 2.0 1.3–114.4 9.4–20.0
trans-Nonachlor 100 83.1 65.1 2.0 9.4–578.2 44.9–94.7
Oxychlordane 100 57.6 42.5 2.1 6.1–390.1 26.3–66.8
aSum of all 14 congeners including congeners not detected in at least 70% of samples.
Table 6. Descriptive statistics for PCB congeners and chlorinated pesticides concentrations detected in
at least 70% of breast milk samples (n = 116). 
Percent Arithmetic Geometric Total
detected mean mean SD Range IQR PCBs
PCBs (µg/kg)
Congener 28 41.0
Congener 52  83.8 7.1 4.2 3.0 0.4–45.1 2.7–9.0 1.5
Congener 99 98.3 35.5 27.4 2.1 2.7–166.8 18.1–41.2 7.5
Congener 101  88.9 6.4 4.3 2.6 0.3–38.2 2.8–7.7 1.3
Congener 105  85.5 4.9 3.2 2.5 0.3–42.6 1.9–5.9 1.0
Congener 118 100 23.1 18.6 1.9 3.7–108.1 12.6–26.0 4.9
Congener 128 56.4
Congener 138 99.1 96.7 78.2 1.9 14.0–408.9 50.6–121.8 20.4
Congener 153 100 164.4 131.6 1.9 21.7–727.9 83.1–207.5 34.6
Congener 156  92.3 12.0 8.3 2.6 0.3–53.5 5.4–15.8 2.5
Congener 170 97.4 25.3 18.5 2.3 0.6–100.3 11.4–34.9 5.3
Congener 180 99.1 61.1 48.0 2.0 10.5–214.2 29.7–82.9 12.9
Congener 183  99.1 10.9 8.8 1.9 1.7–43.8 5.5–13.6 2.3
Congener 187 100 30.7 25.6 1.8 6.2–97.8 17.5–38.1 6.5
Σ 14 congenersa 474.5 385.9 1.9 75.7–1915.8 253.7–579.4
Chlorinated pesticides (µg/kg)
Aldrin 0
β-HCH 96.6 13.4 11.0 1.9 1.3–60.0 7.2–16.9
p,p´-DDE 100 514.9 419.7 1.9 85.9–2295.4 273.8–639.4
p,p´-DDT 96.6 37.8 29.9 2.1 1.0 –161.1 20.3–48.9
Mirex 94.0 8.4 5.8 2.5 0.4–35.2 3.1–10.5
HCB 99.1 59.0 50.2 1.8 7.6–225.8 37.8–72.8
α-Chlordane 3.4
γ-Chlordane 66.7
cis-Nonachlor 99.1 28.3 23.3 1.9 3.2–117.3 16.5–34.0
trans-Nonachlor 99.1 139.0 112.6 1.9 15.3–546.6 77.2–169.1
Oxychlordane 99.1 109.4 81.4 2.1 10.5–642.2 49.8–122.1
aSum of all 14 congeners including congeners not detected in at least 70% of samples.should be possible to identify the specific
deﬁcits attributable to each of these environ-
mental contaminants in this cohort.
The intercorrelations among the Hg mea-
sures reﬂecting the third-trimester exposure—
the cord blood, maternal blood, and maternal
third-trimester hair Hg concentrations—are
high, suggesting that all three measures pro-
vide reliable assessments of third-trimester fetal
exposure. A similar high cord–maternal blood
intercorrelation was recently reported for the
Greenlandic Inuit (9). The cord and maternal
blood Hg measures are less strongly related to
the ﬁrst- and second-trimester hair Hg values.
Hair Hg is approximately 90% MeHg, the
most toxic form of Hg, and has the advantage
of providing a historical record of MeHg
exposure (34). These data suggest that poten-
tial neuropsychological deﬁcits caused by the
impact of Hg on third-trimester brain devel-
opment may be detected more easily using
cord blood or third-trimester hair Hg rather
than hair Hg concentrations averaged across
pregnancy. Conversely, deficits attributable
to Hg exposure early in pregnancy might
well be more readily detected by the first-
trimester hair Hg measure. The average lead
concentration obtained in the Nunavik
cohort is two times higher than that found
in the general population from southern
Québec (41) but about 2.0, 1.5, and 2.0
times lower than those obtained in the devel-
opmental lead studies conducted in Boston,
Massachusetts, Cincinnati, Ohio, and Port
Pirie, Australia, respectively (51–53). The
Nunavik cord blood lead concentration is
similar to that reported by Bjerregaard and
Hansen (9) for the Greenlandic Inuit (32.6
µg/L). Because lead concentration is related
neither to OCs nor to Hg exposure in this
population, lead is not likely to be a con-
founder that will need to be controlled in
analyses examining the developmental effects
of prenatal OCs and Hg exposure.
Selenium is widely distributed in the
environment, and exists naturally in the
form of selenide, elemental Se, selenite, and
selenate. Most Se compounds are water solu-
ble. Data on Se in ﬁsh and marine mammals
are available, especially for specimens col-
lected in the Arctic regions (54). The average
Se whole cord blood concentration found in
this study is 50% higher than that observed
in southern Québec between 1993 and 1998
(arithmetic mean = 2.4 µmol/L, geometric
mean = 2.3 µmol/L, range = 1.3–4.3, n =
178) (55). It is 1.7 times higher than those
found in the cohorts of marine mammal
consumers from the Faroe Islands (48,56).
These data indicate that we should be able to
test hypotheses regarding protective effects
of Se on neurodevelopmental end points
because we observed elevated levels of this
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Table 7. Intercorrelations among PCB congeners detected in at least 70% of cord blood and breast milk samples.
PCB PCB PCB PCB PCB PCB PCB PCB PCB  PCB PCB  PCB
PCB congeners (µg/kg) 52 99 101 105 118 138 153 156 170 180 183 187
Cord blood (n = 98)
PCB 99 0.91* 0.92* 0.90* 0.76* 0.81* 0.82*
PCB 118 0.90* 0.86* 0.71* 0.76* 0.84*
PCB 138 0.98* 0.89* 0.93* 0.95*
PCB 153 0.91* 0.94* 0.93*
PCB 170 0.96* 0.88*
PCB 180 0.93*
PCB 187
Breast milk (n = 116)
PCB 52 0.59* 0.68* 0.57* 0.51* 0.53* 0.51* 0.42* 0.43* 0.41* 0.54* 0.47*
PCB 99 0.64* 0.75* 0.86* 0.91* 0.91* 0.64* 0.80* 0.77* 0.87* 0.79*
PCB 101 0.61* 0.57* 0.51* 0.49* 0.27* 0.33* 0.36* 0.53* 0.46*
PCB 105 0.86* 0.69* 0.68* 0.51* 0.54* 0.54* 0.72* 0.62*
PCB 118 0.87* 0.88* 0.61* 0.71* 0.73* 0.86* 0.80*
PCB 138 0.99* 0.79* 0.90* 0.93* 0.96* 0.94*
PCB 153 0.78* 0.91* 0.94* 0.96* 0.93*
PCB 156 0.86* 0.83* 0.74* 0.74*
PCB 170 0.94* 0.86* 0.87*
PCB 180 0.92* 0.94*
PCB 183 0.96*
PCB 187
Values shown are Pearson r.
*p ≤ 0.000. 
Table 8. Intercorrelations among chlorinated pesticides and PCBs detected in at least 70% of cord plasma and breast milk samples.
Pesticides (µg/kg) β-HCH cis-Nonachlor  p,p´-DDE p,p´-DDT Mirex HBC Oxychlordane  trans-Nonachlor PCB 153
Cord blood (n = 98)
cis-Nonachlor 0.73* 0.73* 0.76* 0.68* 0.83* 0.65*
p,p´-DDE 0.71* 0.76* 0.79* 0.86* 0.89*
p,p´-DDT 0.71* 0.56* 0.71* 0.55*
HCB 0.79* 0.89* 0.72*
Oxychlordane 0.91* 0.87*
trans-Nonachlor 0.85*
Breast milk (n = 116)
β-HCH 0.74* 0.85* 0.65* 0.45* 0.78* 0.82* 0.80* 0.75*
cis-Nonachlor 0.82* 0.79* 0.55* 0.90* 0.86* 0.95* 0.70*
p,p´-DDE 0.76* 0.60* 0.81* 0.88* 0.88* 0.87*
p,p´-DDT 0.52* 0.74* 0.70* 0.76* 0.63*
Mirex 0.54* 0.62* 0.62* 0.79*
HCB 0.86* 0.91* 0.71*
Oxychlordane 0.95* 0.86*
trans-Nonachlor 0.80*
Values shown are Pearson r.
*p  ≤ 0.000. antineurotoxicant and only moderate inter-
correlations with Hg. The strength of the
cord Se–cord Hg association observed in the
Nunavik cohort underscores the importance
of measuring and controlling Se in further
analysis examining the developmental effects
of Hg. A significant but somewhat weaker
cord Se–cord Hg association (r = 0.35) was
observed in the Faroe Islands cohort by
Grandjean et al. (56).
With regard to OC exposure, it is difﬁ-
cult to compare the data in the present study
with those from early PCB neurobehavioral
studies conducted in Michigan (29) and
North Carolina (57), which used packed
column gas chromatography for OC deter-
mination. In Table 11, OC concentrations
observed in the present sample are compared
with those from the general Canadian and
American populations and with more recent
cohort studies using contemporary analytic
methods for PCB determination (congener
specific analysis). For each comparison, we
recalculated the Nunavik OC concentrations
according to the method used in the com-
parison study. For example, to compare our
data with those of the Faroe cohort, where
total PCB exposure was calculated as two
times the sum of congeners 138, 153, and
180, we performed a similar calculation
using the Nunavik data. Comparison of
breast milk and cord plasma PCB and pesti-
cides concentrations show that the prenatal
OC exposure among the Nunavik Inuit is
two to three times higher than that observed
in general populations in southern Québec
and in New Bedford, Massachusetts (58–60).
PCB concentrations in Nunavik are similar to
those found in cord and maternal plasma
samples of the Netherlands study (61); the
Nunavik breast milk PCB concentrations,
however, are somewhat lower. Concentrations
of OCs in cord plasma and breast milk sam-
ples from Nunavik are about two to three
times lower than those found in the groups of
marine mammal consumers from the
Greenland and Faroe Islands cohorts (9,48).
This result suggests that marine mammal con-
sumption may be less frequent in Nunavik
women than in those Arctic groups.
PCB concentrations in plasma and milk
are highly correlated, but levels in milk are
somewhat higher than those in plasma. The
difference in PCB accumulation between
plasma and breast milk lipids could be caused
by a difference in lipid polarity between
plasma and milk. Alternatively, this discrep-
ancy may result from differences in the ana-
lytic methods used to quantify lipids
(gravimetric in milk vs. enzymatic in plasma).
The lower concentrations in cord plasma rela-
tive to maternal plasma are more difﬁcult to
explain because these contaminants are
believed to partition between fat compart-
ment on a 1:1 ratio; however, a similar
cord–maternal plasma ratio (0.87) has been
reported by Bjerregaard and Hansen (9).
OC contaminants are detected more eas-
ily in breast milk because it provides a larger
quantity of fat for analysis; therefore, we
measured certain lower chlorinated con-
geners that could not be detected in the
other two media. However, these low chlori-
nated congeners constitute a very small pro-
portion (only 4%) of the total PCB body
burden as indicated in maternal milk.
Similarly, p,p´-DDT, which breaks down
relatively rapidly in the environment, consti-
tutes a very small proportion (only 4%) of
the total DDT body burden (p,p´-DDT +
p,p´-DDE), indicating that the Arctic expo-
sure consists primarily of the more persistent
forms of these pesticides. By contrast, half
the total DDT (52%) exposure in the
Michigan cohort in the early 1980s con-
sisted of p,p´-DDT, indicating that the
source of that exposure was more recent pes-
ticide use and/or that there was a local
source of DDT (62).
The high intercorrelations of PCB con-
gener 153 with all of the moderate-to-heavily
chlorinated congeners and with most pesti-
cides except p,p´-DDT suggest that congener
153 can be considered a marker for exposure
to most OCs in the Arctic region. Although
several different OC mixtures were intro-
duced into the environment in industrial
countries between the 1930s and 1970s, most
of the lower chlorinated congeners have
biodegraded. These data show that, generally
speaking, the mixture of OC contaminants
persisting in the Arctic today is quite homoge-
neous, so much so that it seems unlikely that
the neurobehavioral effects associated with
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Table 9. Intercorrelations between contaminants
and nutrients.
Cord blood  Cord blood
Contaminants Se DHA
Cord blood PCB 153 0.19 0.27*
(µg/kg lipid basis) (92) (96)
Cord blood mercury 0.51** 0.34**
(µg/L) (92) (93)
Hair mercury, averageda 0.37* 0.51**
(µg/g) (69) (72)
Hair mercury, third  0.45** 0.49**
trimester (µg/g) (70) (73)
Cord blood lead 0.08 0.15
(µg/L) (92) (93)
DHA, docosahexaenoic acid. Values shown are Pearson
r (n). 
aAverage of the total mercury concentrations found at
first, second, and third trimesters of pregnancy. *p ≤
0.05. **p ≤ 0.001. 
Table 10. Comparison of mercury concentrations in Nunavik with those observed in other cohorts.
Geometric
Cohort Medium Years No. mean Range IQR
Canada
Nunavik Inuit Cord blood (µg/L) 1996–2000 95 18.5 2.8–97.0 12.0–27.2
Maternal blood (µg/L) 130 10.4 2.6–44.2 6.6–17.0
Maternal hair (µg/g) 123 3.7 0.3–14.0 2.5–6.2
Southern Québec (41) Cord blood (µg/L)a 1993–1995 1,108 1.0 0.9–1.0b
James Bay Cree (50) Women’s hair, not pregnant (µg/g)c 1992 70 2.5 Maximum = 19.0
Northern Québec Cree (49) Maternal hair (µg/g) 1977–1978 215 6.0d 5.2e
United States (47) Women’s hair, not pregnant (µg/g) 1981 1,274 0.36f 0.14–0.90
1,546 0.24g 0.09–0.62
Faroe Islands
First cohort (18) Cord blood (µg/L) 1986–1987 894 22.9 13.4–41.3
Maternal hair (µg/g) 914 4.3  2.6–7.7
Second cohort (48) Cord blood (µg/L) 1994–1995 163 20.4 1.9–102.0 11.8–40.0
Maternal hair (µg/g) 144 4.1 0.4–16.3 2.5–7.4
Seychelles Island
Main study (20) Maternal hair (µg/g) 1989–1990 740 5.9h 0–25
Pilot study (17) Maternal hair (µg/g) 789 6.6h 0.6–36.4
New Zealand (14) Maternal hair (µg/g) 1978–1984 935i 8.3d 6.0–86.0
Greenland, Disko Bay (9) Cord blood (µg/L) 1994–1996 178 25.3 2.4–181.0
Maternal blood (µg/L) 1994–1996 180 12.8 1.9–75.6
aThe average Hg concentration was reported in nmol/L; this concentration was divided by 5 to convert to µg/L. b95% conﬁdence interval. cWomen 15–39 years old. dArithmetic mean.
eSD. fAmong seafood consumers. gAmong nonseafood consumers. hMedian. iIn the high Hg group.individual congeners and pesticides can be
evaluated in this population.
Dietary fish oils are particularly high in
eicosapentaenoic acid (EPA) and docosahexae-
nioc (DHA) acid, which are n3-PUFAs (63).
High intake of marine mammals is also associ-
ated with increased plasma concentrations of
n3-PUFA (64). Concentrations of n3-PUFA
are not easily compared between studies
because there are important measurement dif-
ferences in laboratory procedures and quantiﬁ-
cation methods. When compared with data
from the southern Québec cohort analyzed in
the same laboratory as those from Nunavik,
DHA concentrations were three times higher
in Nunavik (65). In our cohort, DHA is
weakly correlated with PCB 153 but moder-
ately associated with Hg concentrations.
Dewailly (6) also reported a moderate associa-
tion (r = 0.56) between n3-PUFA and Hg
concentrations in Nunavik Inuit adults. These
data suggest that we will be able to test
hypotheses regarding protective effects of
n3-PUFA. 
The very high OC intercorrelations in the
three media assessed in this data set indicate
that the measurement of PCB and pesticide
concentrations in these specimens are very reli-
able. These associations are lower on a wet
weight basis (data not shown), which may
explain the lower maternal plasma–breast milk
associations found in the Netherlands study
(61). The very high correlations obtained
using the dual capillary column method in the
present study contrast dramatically with the
more modest intercorrelations obtained in the
Michigan study (66) (cord blood–maternal
blood, r = 0.42; cord blood–maternal milk, r =
0.16; maternal blood–maternal milk, r =
0.35). The use of the more reliable measures
in the present study increases the likelihood of
detecting developmental deficits associated
with those exposures. These high intercorrela-
tions will also enable us to assess reliably the
prenatal exposure from any one of these mea-
sures for individuals with incomplete data.
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Table 11. Comparison of OC concentrations in Nunavik with those observed in other cohorts.
Comparison cohorts Nunavik cohort (1996–2000)a
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